Moving and improving for Omicron
Omicron Research Limited, the UK distributor for CAMAG and Distek Inc., is excited to announce that it will be based in new premises from April 2010.
Located in Hungerford, Berkshire, the modern, fully redecorated building will house the office, warehouse and workshop departments of our scientific equipment distribution and support business. For the first time, Omicron’s complete operation will be housed under one roof, providing a more responsive and streamlined service to customers.
A substantial investment has been made into the refurbishment of the new premises and the upgrade of technology, ensuring continuation of the high level of customer service for which Omicron is renowned. With immediate access to the M4, the new location offers staff and clientele a more convenient and professional environment in which to do business.
To coincide with the move the company hase enhanced its website by adding two new functionalities. An extensive parts catalogue is now available on-line, complemented by a new quotation request facility, providing a fast, easy to use service for customers. We invite you to visit and explore our website, www.omicron-uk.com, where you will find information on an extensive range of dissolution, chromatography, spectroscopy, OPLC and capillary electrophoresis products.
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
Manufacturing
Key drivers behind the rise of microsphere drug delivery systems
Microspheres shift drug delivery from broad distribution to precise targeting. These systems improve therapeutic consistency, lower systemic exposure, and adapt to complex treatment regimens. Their growth reflects progress in polymer science, pharmacokinetics, and the push for more individualised care in clinical settings. Let’s explore some of the key drivers behind the rise of microsphere drug delivery systems and look ahead to predict future growth trends
Finance
Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
Syngene International, a global contract research, development, and manufacturing organisation (CRDMO), announces the extension of its long-standing strategic collaboration with Bristol Myers Squibb through 2035
Finance
Novo Nordisk Foundation commits DKK 5.5bn to boost European life sciences innovation
The long-term funding will enable the BioInnovation Institute to expand into new scientific fields and European markets, strengthening translation of academic research into commercial life sciences innovation